GAUCHER DISEASE TYPE 3
Clinical trials for GAUCHER DISEASE TYPE 3 explained in plain language.
Never miss a new study
Get alerted when new GAUCHER DISEASE TYPE 3 trials appear
Sign up with your email to follow new studies for GAUCHER DISEASE TYPE 3, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Groundbreaking trial aims to treat rare diseases in the womb
Disease control Recruiting nowThis study tests whether giving enzyme replacement therapy to fetuses with certain rare genetic diseases (like MPS I, Gaucher, or Pompe) before birth is safe and feasible. About 10 pregnant participants will receive the treatment through the umbilical vein. The goal is to see if …
Matched conditions: GAUCHER DISEASE TYPE 3
Phase: PHASE1 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Cough medicine repurposed: ambroxol registry launches for rare brain diseases
Knowledge-focused Recruiting nowThis study creates a registry to collect real-world information on the safety and effectiveness of ambroxol, a common cough medicine, when used at higher doses for Gaucher disease or GBA-related Parkinson disease. Researchers aim to gather data from 300 patients worldwide who are…
Matched conditions: GAUCHER DISEASE TYPE 3
Sponsor: Shaare Zedek Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
New brain scan study seeks clues to rare gaucher disease
Knowledge-focused Recruiting nowThis study uses a special MRI technique called magnetic resonance spectroscopy to measure brain chemicals in adults with Type 3 Gaucher disease. The goal is to find markers that show how the disease affects the brain and how it responds to treatment. About 5 participants aged 18 …
Matched conditions: GAUCHER DISEASE TYPE 3
Sponsor: University of Minnesota • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC